These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4425313)

  • 21. Immunisation of cattle against the herpesvirus of malignant catarrhal fever: failure of inactivated culture vaccines with adjuvant.
    Plowright W; Herniman KA; Jessett DM; Kalunda M; Rampton CS
    Res Vet Sci; 1975 Sep; 19(2):159-66. PubMed ID: 1166120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversal of H-2-restricted hyporesponsiveness to human growth hormone by the use of aluminum hydroxide as adjuvant.
    Bomford R; Aston R; Ivanyi J
    Immunogenetics; 1985; 21(5):505-9. PubMed ID: 2581892
    [No Abstract]   [Full Text] [Related]  

  • 24. Recombinant DNA technology for producing new rinderpest virus vaccines.
    Barrett T
    Expert Rev Vaccines; 2005 Feb; 4(1):113-20. PubMed ID: 15757478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on vaccines against bovine ephemeral fever.
    Tzipori S; Spradbrow PB
    Aust Vet J; 1973 Apr; 49(4):183-7. PubMed ID: 4711145
    [No Abstract]   [Full Text] [Related]  

  • 26. Fluorescent antibody study of a new bovine herpesvirus (strain DN-599).
    Sass B; Mohanty SB; Hetrick FM
    Am J Vet Res; 1974 Oct; 35(10):1343-6. PubMed ID: 4371526
    [No Abstract]   [Full Text] [Related]  

  • 27. [Study of the immunostimulating activity of 3 imidazole derivatives with anthelminthic action, on bovipestic, peripneumonic and anthrax immunogenesis].
    Provost A; Tacher G; Borredon C
    Rev Elev Med Vet Pays Trop; 1974; 27(1):39-52. PubMed ID: 4216052
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum electrophoretic pattern of buffalo calves vaccinated with cell culture rinderpest vaccine.
    Sharma SK; Murty DK
    Indian J Exp Biol; 1974 Nov; 12(6):535-6. PubMed ID: 4464256
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect exerted on depot immunization by the previous administration of complete Freund adjuvans (author's transl)].
    John C; Mára M; Morávková M; Benesová K
    Cesk Epidemiol Mikrobiol Imunol; 1974 Aug; 23(4-5):205-17. PubMed ID: 4279775
    [No Abstract]   [Full Text] [Related]  

  • 30. Vaccinia virus recombinant vaccines for rinderpest.
    Yilma T
    Dev Biol Stand; 1995; 84():201-8. PubMed ID: 7796955
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of an enzyme-linked immunosorbent assay for the detection of IgG antibodies to rinderpest virus in epidemiological surveys.
    Anderson J; Rowe LW; Taylor WP
    Res Vet Sci; 1983 Jan; 34(1):77-81. PubMed ID: 6340173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of infectious bovine rhinotracheitis virus immunization on viral shedding in challenge-exposed calves treated with dexamethasone.
    Rossi CR; Kiesel GK
    Am J Vet Res; 1982 Sep; 43(9):1576-9. PubMed ID: 6293350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of interferon in protection of rabbits against rinderpest virus.
    Fujisaki Y; Ishii S; Watanabe M
    Natl Inst Anim Health Q (Tokyo); 1968; 8(3):122-31. PubMed ID: 5712545
    [No Abstract]   [Full Text] [Related]  

  • 34. Research collaborations on rinderpest.
    Konnerup N
    J Am Vet Med Assoc; 2000 Jan; 216(2):176. PubMed ID: 10649747
    [No Abstract]   [Full Text] [Related]  

  • 35. 19 S neutralizing antibody produced in guinea pigs by rabies virus.
    Fujisake Y; Sekiguchi K; Hirasawa K
    Natl Inst Anim Health Q (Tokyo); 1968; 8(3):132-9. PubMed ID: 5712546
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on the immunizing potency of tick-borne encephalitis vaccines.
    Gall W
    Acta Microbiol Pol A; 1973; 5(3):279-85. PubMed ID: 4769562
    [No Abstract]   [Full Text] [Related]  

  • 37. Response of virus diarrhea-mucosal disease-convalescent calves and rinderpest-vaccinated calves to inoculation with heterologous virus.
    DeLay PD; Kniazeff AJ
    Am J Vet Res; 1966 Mar; 27(117):512-8. PubMed ID: 5959401
    [No Abstract]   [Full Text] [Related]  

  • 38. [Adaptation in microtest of the seroneutralization technic by the kinetic method for the research and titration of antibodies neutralizing the rinderpest virus].
    Rioche M
    Rev Elev Med Vet Pays Trop; 1969; 22(4):465-71. PubMed ID: 5408391
    [No Abstract]   [Full Text] [Related]  

  • 39. Hyperimmune serum against Myxovirus Parainfluenza-3 and bovine adenovirus in prophylaxis of respiratory diseases in calves.
    Haralambiev H; Draganov M; Zwetkov P
    Arch Exp Veterinarmed; 1972; 26(2):273-6. PubMed ID: 4343079
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of Montanide adjuvants, IMS 3012 (Nanoparticle), ISA 206 and ISA 35 (Emulsion based) along with incomplete Freund's adjuvant for hyperimmunization of equines used for production of polyvalent snake antivenom.
    Waghmare A; Deopurkar RL; Salvi N; Khadilkar M; Kalolikar M; Gade SK
    Vaccine; 2009 Feb; 27(7):1067-72. PubMed ID: 19100805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.